Other Clinical Trial - PET Imaging in ALS Patients

Status Completed

Clinical Trial Summary

This is a pilot study to evaluate a potential imaging biomarker for aiding diagnosis and monitoring progression of ALS, based on a well established basic science pathway, published human autopsy data, preliminary data in ALS mutant mice, and our recently published data using brain PET scans to image the metabotropic glutamate receptor type 5 (mGluR5) in healthy human volunteers.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS)
Motor Neuron Disease
Sclerosis

Clinical Trial Details

NCT number	NCT02236897
Study type	Interventional
Source	Johns Hopkins University
Contact
Status	Completed
Phase	N/A
Start date	August 2013
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02365922` - Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Completed	`NCT01699451` - DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida
Completed	`NCT04577404` - Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)	Phase 3
Terminated	`NCT03580616` - Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Completed	`NCT01884571` - Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Completed	`NCT02118805` - Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
Completed	`NCT00244244` - A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS	Phase 2
Active, not recruiting	`NCT00420719` - Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)	N/A
Completed	`NCT02936635` - A Study for Patients Who Completed VITALITY-ALS (CY 4031)	Phase 3
Withdrawn	`NCT04055532` - Biomarkers in Neurodegenerative Diseases
Completed	`NCT03645031` - Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease	N/A
Completed	`NCT01786603` - Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Completed	`NCT02559869` - Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
Completed	`NCT01592552` - A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
Completed	`NCT00403104` - Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Recruiting	`NCT02424669` - Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients	N/A
Completed	`NCT02017912` - Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS	Phase 2
Completed	`NCT01366027` - PRISM Registry: Pseudobulbar Affect Registry Series	N/A
Completed	`NCT00330681` - Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)	Phase 3
Completed	`NCT00876772` - Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)	Phase 2/Phase 3